# Association of FV G1691A, FV H1299R, and FII G20210A variations with thrombosis and coronary artery disease (CAD): A population-based study

**Authors:** Özmen Sevda Ünallı, Yeşim Özarda, Aylin Köseler, Ramazan Sabırlı, Derya Sucu Kaynak, Ibrahim Koç

PMC · DOI: 10.5937/jomb0-39668 · Journal of Medical Biochemistry · 2025-06-13

## TL;DR

This study found no significant link between specific gene variations and coronary artery disease in a Turkish population.

## Contribution

The study contributes population-specific insights into the role of FV and FII gene variations in CAD in Turkey.

## Key findings

- No significant differences in genotype frequencies of FV G1691A, FV H1299R, and FII G20210A were found between CAD and control groups.
- Allele frequencies of these gene variations did not differ significantly between CAD patients and healthy individuals.
- The results suggest these gene variations may not be major contributors to CAD in the Turkish population studied.

## Abstract

Thrombosis and coronary artery disease (CAD) are complex disorders influenced by genetic factors. Specific gene variations, such as Factor V (FV) G1691A (Leiden), FV H1299R, and Prothrombin (FII) G20210A, have been implicated in thrombotic events and CAD. However, their precise role in CAD development remains controversial. This study investigated the prevalence and association of these gene variations with thrombosis and CAD in the Turkish population.

A case-control study included 406 healthy individuals and 64 CAD patients. Genotyping for FV G1691A, FV H1299R, and FII G20210A was performed using a strip assay. Fisher's exact test compared allele and genotype frequencies between the CAD and control groups.

No significant differences were observed in genotype frequencies of FV G1691A, FV H1299R, and FII G20210A between the CAD and control groups (p>0.05). Similarly, allele frequencies did not differ significantly between the two groups (p>0.05).

The findings suggest that FV G1691A, FV H1299R, and FII G20210A variations may not play a significant role in the development of CAD in the Turkish population studied. These results are consistent with the existing conflicting literature on the association between these gene variations and CAD. Further research with larger sample sizes and diverse populations is warranted to elucidate the role of these variations in CAD pathogenesis.

## Linked entities

- **Diseases:** thrombosis (MONDO:0000831), coronary artery disease (MONDO:0005010), CAD (MONDO:0005010)

## Full-text entities

- **Genes:** F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, F5 (coagulation factor V) [NCBI Gene 2153] {aka FVL, PCCF, RPRGL1, THPH2, fV}
- **Diseases:** Thrombosis (MESH:D013927), CAD (MESH:D003324)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G1691A, H1299R, G20210A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12357640/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12357640/full.md

---
Source: https://tomesphere.com/paper/PMC12357640